You are subscribed to the Contemporary Pediatrics eNewsletter.

November 4, 2014     Web Version     Digital Edition     Print / Digital subscribe     eNewsletter Subscribe

Today's Headlines

FDA approves first meningococcal B vaccine

The first vaccine licensed in the United States to immunize young persons aged 10 through 25 years against invasive meningococcal disease caused by Neisseria meningitidis serogroup B has been approved by the US Food and Drug Administration. Find out the details.

Cystic fibrosis: An essential update

The prognosis for patients with cystic fibrosis (CF) continues to improve because of a combination of advances in the understanding of disease pathophysiology, implementation of early screening and diagnosis, and greater emphasis on proactive management to prevent deterioration and disease progression. How has the treatment changed?

Alternative medicine for atopic dermatitis

The mainstay of current treatment for atopic dermatitis is the use of topical steroids and calcineurin inhibitors. However, increasing numbers of patients and parents are turning to complementary and alternative treatments. Why is this?

VIDEO

What does the new CDC report say about HPV vaccine rates?

video

Listen to Anne Schuchat, MD, assistant surgeon general in the US Public Health Service and director of the CDC's National Center of Immunization and Respiratory Diseases, discuss promiscuity and the HPV vaccine. » More with video.

See more videos from Contemporary Pediatrics here.

 

HAVE YOU READ THESE?

New policy for meningococcal vaccines

Alternative medicine used for autism

Managing eczema

Vaccine schedule update

Kids with cystic fibrosis living longer

SHARE YOUR PUZZLER

Have a puzzling pediatric case that you'd like to share with fellow readers? We're looking for stories about intriguing diagnoses that have stumped the experts! Check out past Puzzlers


Contact CRadwan@advanstar.com requesting our guidelines, then send us your Puzzler and we'll let you know if your submission for publication has been accepted.

 
Powered by Modern Medicine Advanstar Medical Communications Group